EFSF is a real champ. The stock could easily have fallen apart in this big market decline, but it is trading solidly within 10% of its all time OTC Journal high. The stock appreciated 150% since I first introduced it to subscribers; this is remarkable when considering the current market climate. Its stubborn refusal to give ground provides a hint that this one might just power much higher when the microcap switch flips back on.
If you are wondering where I would buy it right now, here’s a very short term chart that will give you an idea:
The chart measures the 61.8% retracement from the recent move the stock made in conjunction with the news of WalMart carrying the Cinnergen product.
Here’s what the chart tells you- On a very short term basis, the stock should be accumulated if it gets into the $.415 range.
If you wait patiently, and the overall market continues to grind as it has the last several weeks, I would expect this stock to probably drift down to that level. Of course, news could drive it up.
Here’s a chart of the downtrend line, which I believe is screaming a message at anyone who believes charts mean something in the stock market. This downtrend line goes back to the very first trade in the stock, and it has never been convincingly broken to the upside. It represents nearly three years. The longer term your look, the better predictor of behavior.
The stock has made two attempts to bust through this downtrend line this year. The stock is not giving much ground on the pullbacks, which means there is a loyal shareholder base with a long term perspective.
It might take 1, 2, or 3 more attempts to bust that downtrend line, but I believe it is inevitable. Once it breaks through convincingly, it will be tough to predict how high it could go.
Bottom line: My suggestion is don’t sell it if you own if you are trying to buy it back cheaper. It’s too risky- the company could deliver something big.
Accumulate at or around the $.415 level if it gets there.
Comments and questions are welcome.
How could you say that the .383 retracement is not the perfert spot to buy as it has proved this week?The stock shined out this week with the major sell off in the broad markets. When and I think soon Monday or Tues the markets will make a reversal. EFSF will start to make an assalt on a new high for the year. The future is much brighter than the past for this stock.OraPhyte will get EFSF a major backer or Partner and this sub dollar price will be a thing of the past.Enjoy your succsess you my friend have picked a winner.
Editor: Easy- I said it. I don’t know that it’s going there for sure. On retracements, if the 38.2% retracement holds, that ends up being the buy point. If it doesn’t, you look at the 61.8%. Here’s the beauty of the 61.8- if it gives way, you know you have much bigger problems, and you can set about a 10% stop loss from a 61.8. Who knows what will happen?- I just give ideal entry levels, and I was right last time. You are right- this stock has held up beautifully in a tough market. That’s a bullish sign for a strong market.
I have been following this stock for a few years and have been accumulating it since 2005. I am intrigued by their technology and especially by a comment that was made during an audio interview last year. They appear to have the ability to ‘tune’ their food based remedies and go after envelope viruses. The ramifications of this technology, if they can prove it works in human trials and deliver it, is so huge that in my opinion the stock price has the potential of very large growth.
Editor: Well, this morning’s news out to have all of us pretty excited. If they can get in bed with Dupont, look out above.
How will the Form 10QSB “Quarterly Report” affect the stock? Or is it nothing new?
Editor: I haven’t had a chance to read it yet, but I believe whatever negative there might be would be overshadowed by this AM’s announcement about Dupont.
I am so glad that I bought my shares when I did @ $0.214/share. I am sitting on mine and waiting it out!
Editor: You should like it even more today.
This morning news was great. I also was wondering about the acne medicine Pur Effect. I understand the company CK41 was suppose to release information in the first quarter about this product. Who the celebrities were and when it would be aired. I have e-mailed them and have gotten no response about it Do you have any info to share?
Editor: The only info I can share is that you are right- I am informed CK41 is working on the project, does have some names lined up, and will get going at some point in the future. Beyond that, I cannot share anything that is not public information.
Any comment the latest two PRs?
Thanks
Editor: http://www.otcjournal.com/archive/listserv/20070321-1.html
Do you still think that the stock could pull back to $0.415? I still want to get a good deal so I’m watching NIHK as well.
Editor: Of course it could. But, then again, it might not. Don’t wonder about it. Just act if it does.
Hi there!!! All I have to say about Efoodsafety is LOOK OUT!!!… because this stock WILL be soring higher in the near future. Especially with the distribution of Cinnergen this is only the beginning for Efoodsafety. I will gaurantee people that this stock will not be a otcbb stock or (Penny stock) much longer. Sooner or later this stock is ready to blow. Its just a matter of time and a lil patience. This is a stock that more people I think should be looking at.
Editor: If they hit on just one of the many exciting products, it will change the company completely. Lots of opportunities for a home run here. The Dupont deal is just one example. If Dupont moves on this product, look out above.
Do you have a view on stealth 10-Q’s? This company trumpets every whiff of future pay-offs, then files quarterly results without a press release, conference call, or guidance. I wouldn’t have known about the quarterly results if you hadn’t mentioned them!) At the end of the day, there are only two types of managers: those who see shareholders as partners, and those who see them as food. This company’s communications style points toward the latter. I can’t complain about the stock’s performance – I’m in from .21 at your recommendation – but I sure wish I could like the company as much as the market likes the stock. My inclination is to take my bait back.
Editor: Lots of potential homeruns for this company which could change your viewpoint. Here are my comments:
http://www.otcjournal.com/archive/listserv/20070321-1.html
EFSf 3rd numbers are now out. The number of outstanding shares stayed the same, the float was only 13 million less. What happened to the 30 million shares they were supposed to get back and take off the board? Can you please find out.
Editor: I’m not sure where you are getting your information. I looked at last quarter and this past quarter. The I&O went from 180 to 150.
Forget about the stockholders for a moment. Every development within efsf is of vast benefit to mankind. If any or most of its potential are successful humanity will benefit and the stock will soar. I imagine being able to destroy those deadly bacilli will rank it with penicillin or sulpha drugs. How wonderful to be able to help manking and also profit by doing so. More power to you, EFSF.
alblanche@aol.com
Editor: The theme of the company is very topical for the coming years. I also like the theme of finding natural, less toxic solutions for these very difficult problems. Patience should be rewarded here, but you still have to buy right.
in a nutshell…what are your thoughts? A good time to jump in/add… or is your SSL holding true and get out till this drop shows more signs of ending? A few red days in a row here… this company has a lot going for it and as you have said one (right) PR can turn this around to .50 real fast… but in the meantime the market isnt giving it its due price…
thanks in advance…
Editor: I like the fact that it sold off down the about $.37, the rebounded and tried for $.40 again. If this market correction is close to running its course, this one could be stellar in the next move up. Can’t say for sure the pain is over. Oil needs to come back down.
Can you please give an update as to whats going on with EFSF. They have been on a downward slide the last couple weeks. Is there anything foreseable in the near future that will cause this stock to rise towards the .50 again? When can we expect to hear the Dupont results?
Editor: In my view, the stock is simply going through a long overdue correction/quiet trading period. No problem. When activity picks up at the company, the stock probably will as well. We’ll hear more about Dupont when the company has something to say. No telling when.
Do you think the recent push in the stock price ($.35 – today’s closing of $.39) is attributed to your blog? There isn’t any news that I’m missing right? If I am not missing news, this stock should drift back down on no news, right?!
Editor: I can’t say for sure, but it seems likely since I have made some good calls on this stock. I could easily drift back down.
Could you tell me something about the company. Location, How many employees: chemists, biologists, medical doctors? Does it have patents on all its products When does its next earnings report come out? Thank you in advance. alblanche
Editor: The company is located in Scottsdale, AZ. They do not employ scientists- they acquired already developed technologies – they outsource the research needs, so it is really a marketing company that owns technologies. Year end earnings are due out by the end of this month, but I’m not expecting any numbers- they had their first commercial product- Cinnergen- introduced earlier this year and they are just starting to generate sales. Here my original presentation on the company:
http://www.otcjournal.com/archive/listserv/20070110-1.html
This is quite old now- back to January. The products are still pretty much the same, but the stock was below $.20 at the time and ready for a rebound. From here, I believe it will require more corporate achievement to atttain much higher levels. This is a high risk, high reward idea.